Amicus Therapeutics Stock Forecast - Price Action Indicator
| FOLD Stock | USD 14.27 0.08 0.56% |
Amicus Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Amicus Therapeutics stock prices and determine the direction of Amicus Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Amicus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time The value of RSI of Amicus Therapeutics' share price is above 80 . This usually indicates that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 82
Buy Peaked
Oversold | Overbought |
Using Amicus Therapeutics hype-based prediction, you can estimate the value of Amicus Therapeutics from the perspective of Amicus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Amicus Therapeutics after-hype prediction price | USD 14.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Amicus Therapeutics to cross-verify your projections. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.Amicus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Amicus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amicus using various technical indicators. When you analyze Amicus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.01) | (0.05) |
| Check Amicus Therapeutics Volatility | Backtest Amicus Therapeutics | Information Ratio |
Amicus Therapeutics Trading Date Momentum
| On January 26 2026 Amicus Therapeutics was traded for 14.27 at the closing time. The top price for the day was 14.29 and the lowest listed price was 14.27 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Amicus Therapeutics to competition |
Other Forecasting Options for Amicus Therapeutics
For every potential investor in Amicus, whether a beginner or expert, Amicus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Amicus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Amicus. Basic forecasting techniques help filter out the noise by identifying Amicus Therapeutics' price trends.Amicus Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amicus Therapeutics stock to make a market-neutral strategy. Peer analysis of Amicus Therapeutics could also be used in its relative valuation, which is a method of valuing Amicus Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Amicus Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Amicus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amicus Therapeutics shares will generate the highest return on investment. By undertsting and applying Amicus Therapeutics stock market strength indicators, traders can identify Amicus Therapeutics entry and exit signals to maximize returns.
Amicus Therapeutics Risk Indicators
The analysis of Amicus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Amicus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting amicus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.62 | |||
| Standard Deviation | 4.05 | |||
| Variance | 16.44 | |||
| Downside Variance | 1.39 | |||
| Semi Variance | (0.19) | |||
| Expected Short fall | (2.21) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Amicus Therapeutics
The number of cover stories for Amicus Therapeutics depends on current market conditions and Amicus Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amicus Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amicus Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Amicus Therapeutics Short Properties
Amicus Therapeutics' future price predictability will typically decrease when Amicus Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amicus Therapeutics often depends not only on the future outlook of the potential Amicus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amicus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 304.4 M | |
| Cash And Short Term Investments | 249.9 M |
Check out Historical Fundamental Analysis of Amicus Therapeutics to cross-verify your projections. For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.